<DOC>
	<DOC>NCT00537238</DOC>
	<brief_summary>This study will compare pregabalin and levetiracetam in patients with partial seizures. It will also evaluate the safety and tolerability of pregabalin and levetiracetam in these patients.</brief_summary>
	<brief_title>Pregabalin Versus Levetiracetam In Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Subjects (male or female) must be &gt; 18 years of age, with a diagnosis of epilepsy with partial seizures, as defined in the International League Against Epilepsy (ILAE) classification of seizures. Partial seizures may be simple or complex, with or without secondary tonicclonic generalization. Subjects must be have been diagnosed with epilepsy for at least 2 years, and must have been unresponsive to treatment with at least two but no more than five prior antiepileptic drugs (AEDs), and at the time of study enrollment are on stable dosages of 1 or 2 standard AEDs. Females who are pregnant, breastfeeding, or intend to become pregnant during the course of the trial will be excluded Subjects with other neurologic illness that could impair endpoint assessment, or subjects with LennoxGastaut syndrome, absence seizures, status epileptics within the 12 months prior to trial entry, or with seizures due to an underlying medical illness or metabolic syndrome, will be excluded.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Epilepsies partial</keyword>
	<keyword>Partial Seizure Disorder</keyword>
	<keyword>Complex Partial Seizure Disorder</keyword>
	<keyword>Epilepsy</keyword>
</DOC>